In-Vitro Diagnostic Substances, Reagents, Test Kits

SOL #: N3239826Q4997Special NoticeSole Source

Overview

Buyer

Dept Of Defense
Dept Of The Navy
NAVAL MEDICAL RESEARCH CENTER
SILVER SPRING, MD, 20910-7500, United States

Place of Performance

Place of performance not available

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Feb 25, 2026
2
Action Date
Mar 2, 2026, 8:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The United States Department of the Naval Medical Research Command (NMRC) intends to award a sole source contract to BioFire Defense LLC for In-Vitro Diagnostic Substances, Reagents, Test Kits. Specifically, this requirement is for Buffer 10X w/ BSA. This notice is for informational purposes, but the Government will consider responses from interested parties.

Scope of Work

The requirement is for 3000 units of Cat#: 1768, Buffer 10X w/ BSA - 50mM MgCL(2), with an orange cap.

Contract & Timeline

  • Type: Special Notice (Sole Source Intent)
  • Intended Awardee: BioFire Defense LLC
  • NAICS Code: 325413 (In-Vitro Diagnostic Substances, Reagents, Test Kits)
  • Procurement Method: FAR Part 12 Commercial Items
  • Response Due: March 2, 2026, 8:00 PM ET
  • Published: February 25, 2026

Additional Notes

All contractors must be registered with the System for Award Management (SAM.gov) and possess a Unique Entity Identification Number (UEI) to be eligible for award. Registration information is available at www.sam.gov or by calling (866) 606-8220. This notice is not a request for competitive proposals.

People

Points of Contact

Nataki JOHNSONPRIMARY
Sataria BeySECONDARY

Files

Files

No files attached to this opportunity

Versions

Version 1Viewing
Special Notice
Posted: Feb 25, 2026
In-Vitro Diagnostic Substances, Reagents, Test Kits | GovScope